Pediatric Cefazolin Dosing
For pediatric patients beyond the neonatal period, administer cefazolin at 25-50 mg/kg/day divided into 3-4 equal doses (every 6-8 hours) intravenously for mild to moderately severe infections, with doses increased to 100 mg/kg/day for severe infections.
Standard Dosing Regimens
The FDA-approved dosing for pediatric patients is clearly defined 1:
Mild to Moderately Severe Infections
- Total daily dose: 25-50 mg/kg/day
- Divided into: 3 or 4 equal doses
- Frequency: Every 8 hours (3 doses) or every 6 hours (4 doses)
- Route: Intravenous (IV) or intramuscular (IM)
Severe Infections
- Total daily dose: Up to 100 mg/kg/day (45 mg/lb)
- Divided into: 3 or 4 equal doses
- Route: IV preferred
Practical Dosing Examples
For a 20 kg child:
- Mild-moderate infection (25 mg/kg/day): 165 mg every 8 hours OR 125 mg every 6 hours
- Moderate-severe infection (50 mg/kg/day): 330 mg every 8 hours OR 250 mg every 6 hours
- Severe infection (100 mg/kg/day): 665 mg every 8 hours OR 500 mg every 6 hours
Specific Clinical Contexts
Necrotizing Skin/Soft Tissue Infections (Staphylococcus aureus)
For methicillin-susceptible S. aureus necrotizing infections, the IDSA guideline recommends 33 mg/kg/dose every 8 hours IV 2. This translates to approximately 100 mg/kg/day, aligning with the severe infection dosing.
Complicated Intra-abdominal Infections
The SIS/IDSA guidelines do not provide a specific cefazolin dose for intra-abdominal infections, as broader-spectrum agents are typically preferred 3. However, when used, standard dosing applies.
Renal Dose Adjustments
Adjust doses based on creatinine clearance (CrCl) 1:
- CrCl 70-40 mL/min: Give 60% of normal daily dose divided every 12 hours
- CrCl 40-20 mL/min: Give 25% of normal daily dose divided every 12 hours
- CrCl 20-5 mL/min: Give 10% of normal daily dose every 24 hours
All adjustments require an initial loading dose appropriate to infection severity.
Critical Caveats
Neonatal Exclusion
Cefazolin is NOT recommended for premature infants and neonates due to lack of established safety data 1. This is an absolute contraindication in the FDA labeling.
Cardiac Surgery with Cardiopulmonary Bypass (CPB)
Standard weight-based dosing may be inadequate during CPB. Recent pharmacokinetic studies demonstrate that:
- Standard 50 mg/kg every 4-6 hours achieves target concentrations <70% of the time during CPB 4
- Additional dosing into the CPB circuit is necessary: At least 30 mg per 100 mL of CPB priming volume 5
- Continuous infusion regimens may be superior to intermittent dosing in this population 4
This represents a significant gap between standard recommendations and optimal exposure during cardiac surgery.
Administration Details
- IV bolus: Administer over 3-5 minutes after dilution 1
- Intermittent infusion: Dilute in 50-100 mL compatible solution
- IM injection: Inject into large muscle mass; pain is infrequent
Route of Administration
Intravenous administration is strongly preferred for hospitalized pediatric patients with serious infections. IM administration is acceptable but less commonly used due to:
- Need for large muscle mass in small children
- Slower achievement of peak concentrations
- Patient discomfort with repeated dosing
The evidence consistently supports IV dosing for optimal tissue penetration and predictable pharmacokinetics 6.